Generic Name: palbociclib (PAL boe SYE klib)
Brand Name: Ibrance
Dosage Forms: oral capsule (100 mg; 125 mg; 75 mg); oral tablet (100 mg; 125 mg; 75 mg)
What is palbociclib?
Palbociclib is used in men and women to treat HR-positive, HER2-negative breast cancer that has spread to other parts of the body.
Palbociclib may also be used for purposes not listed in this medication guide.
Palbociclib affects your lungs or your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, chest pain, shortness of breath, or cough with or without mucus.
Before taking this medicine
Tell your doctor if you have signs of infection (such as fever or chills), or if you have ever had:
liver disease; or
Palbociclib can harm an unborn baby or cause birth defects if the mother or the father is using palbociclib.
If you are a woman, do not use palbociclib if you are pregnant. You may need to have a negative pregnancy test before starting this treatment. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 3 weeks after your last dose.
If you are a man, use effective birth control if your sex partner is able to get pregnant. Keep using birth control for at least 3 months after your last dose.
Tell your doctor right away if a pregnancy occurs while either the mother or the father is using palbociclib.
This medicine may affect fertility (ability to have children) in men. However, it is important to use birth control to prevent pregnancy because palbociclib can harm an unborn baby.
You should not breastfeed while using this medicine and for at least 3 weeks after your last dose.
How should I take palbociclib?
Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed.
Palbociclib is given in a 28-day treatment cycle, and you may only need to take the medicine during the first 3 weeks of each cycle. Your doctor will determine how long to treat you with palbociclib.
Take palbociclib capsules with food. Avoid grapefruit products. Grapefruit may interact with palbociclib and lead to unwanted side effects.
You may take palbociclib tablets with or without food.
Take the medicine at the same time each day.
Swallow the capsule or tablet whole and do not crush, chew, break, or open it. Do not use a broken or damaged pill.
If you vomit after taking palbociclib, wait until the next day to take your next dose.
Palbociclib affects your immune system. You may get infections more easily, even serious or fatal infections. Your doctor will need to examine you on a regular basis.
Store at room temperature away from moisture and heat.
What happens if I miss a dose?
Skip the missed dose and do not take the medicine again until the next day. Do not use two doses at one time.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking palbociclib?
Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.
Palbociclib side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
blisters or ulcers in your mouth, red or swollen gums, trouble swallowing;
signs of inflammation in the lungs--new or worsening cough, painful or difficult breathing, wheezing, feeling short of breath even while resting; or
signs of a blood clot in the lung--chest pain, sudden cough, wheezing, rapid breathing, coughing up blood.
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Common side effects may include:
low blood cell counts, infections;
easy bruising or bleeding;
feeling weak or tired;
abnormal liver function tests;
dry skin, rash;
altered sense of taste;
thinning hair or hair loss.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Palbociclib dosing information
Usual Adult Dose for Breast Cancer:
28-day cycle: 125 mg orally once a day for 21 consecutive days followed by 7 days off
-Administer the recommended dose of an aromatase inhibitor when given with this drug. Refer to the prescribing information for the aromatase inhibitor being used.
-When given with this drug, the recommended dose of fulvestrant is 500 mg on Days 1, 15, 29, and once monthly thereafter. Refer to the prescribing Information for fulvestrant.
-Pre/perimenopausal women treated with the combination of this drug plus fulvestrant should be treated with luteinizing hormone-releasing hormone (LHRH) agonists according to local protocol.
Use: For HR-positive, HER2-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women OR fulvestrant in women with disease progression following endocrine therapy.
What other drugs will affect palbociclib?
Other drugs may affect palbociclib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Frequently asked questions
- How much does Ibrance cost?
- How common is hair loss with Ibrance?
- Is Verzenio better than Ibrance?
- Is Ibrance a form of chemo?
- Can you take Verzenio after Ibrance fails?
More about palbociclib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- 72 Reviews
- Drug class: CDK 4/6 inhibitors
- FDA Alerts (1)
- Other brands
Related treatment guides
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2021 Cerner Multum, Inc. Version: 4.02.